In the this TEDMED talk, Francis Collins, MD, PhD, director of the National Institutes of Health, discusses bridging the gap between basic science and clinical applications in the drug development process. Repurposing existing drugs and testing on fabricated human tissue are two ways that Collins identifies in his talk as potential methods for getting disease treatments to market faster.
Stanford researchers are also working to make translational medicine a reality through the School of Medicine’s SPARK program, which creates partnerships between scientists and entrepreneurs to promote innovative research.
Previously: Re-engineering the drug-development process to speed medical advances, Accelerating the translation of biomedical research into clinical applications and Why drug development is time consuming and expensive (hint: it’s hard)
Via Medgadget
